MRD Assessment Threshold Interpreter

Next-Generation Flow (NGF) provides rapid results (hours) but depends on fresh samples. Next-Generation Sequencing (NGS) offers higher sensitivity (10⁻⁶) and can use stored samples, but requires a baseline tracking sample (the "molecular signature").

The term "Minimal Residual Disease" is increasingly being replaced by "Measurable Residual Disease" to reflect improved detection capabilities.